Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 9
Vpliv sreče na delovnem mestu na uspešnost zaposlenih
Ivana Komel, Matej Černe, Matej Lahovnik, Vlado Dimovski
Magistrsko delo
Oznake: delo;delovno mesto;sreča;zadovoljstvo;delovna uspešnost;meritve;management;raziskave;analiza;
Vpliv sreče na delovnem mestu na uspešnost zaposlenih
Leto: 2022 Vir: Ekonomska fakulteta (UL EF)
Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy
Alja Zottel, Alja Zottel, Ivana Jovchevska, Neja Zupanec, Radovan Komel
Pregledni znanstveni članek
Oznake: citoskelet;glioblastom;označevalci;cytoskeleton;glioblastoma;biomarkers;
Glioblastoma, the most common primary brain malignancy, is an exceptionally fatal cancer. Lack of suitable biomarkers and efficient treatment largely contribute to the therapy failure. Cytoskeletal proteins are crucial proteins in glioblastoma pathogenesis and can potentially serve as biomarkers and ...
Leto: 2021 Vir: Medicinska fakulteta (UL MF)
Estetika lenobe, solarni punk in avantgarda
Ivana Zajc, Kristina Pranjić, Peter Purg, Andrej Pezelj, Magdalena Germek, Primož Mlačnik, Alenka Ambrož, Mirt Komel
Drugi članki ali sestavki
Oznake: ekologija;kritika;literatura;umetnost;imaginarij rasti;avantgarda;odrast;solarni punk;ekozofija;
Estetika lenobe, solarni punk in avantgarda: Kako lahko humanistika misli ekološko krizo?
Leto: 2022 Vir: Repozitorij Univerze v Novi Gorici (RUNG)
High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomas
Ivana Jovchevska, Alja Zottel, Neja Zupanec, Jernej Mlakar, Maxim Sorokin, Daniil Nikitin, Anton A. Buzdin, Radovan Komel
Izvirni znanstveni članek
Oznake: glioblastoma;malignancy;FREM2;SPRY1;TCGA;
World Health Organization grade IV diffuse gliomas, known as glioblastomas, are the most common malignant brain tumors, and they show poor prognosis. Multimodal treatment of surgery followed by radiation and chemotherapy is not sufficient to increase patient survival, which is 12 to 18 months after ...
Leto: 2019 Vir: Medicinska fakulteta (UL MF)
Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
Alja Zottel, Ivana Jovchevska, Neja Zupanec, Jernej Mlakar, Jernej Šribar, Igor Križaj, Marija Skoblar Vidmar, Radovan Komel
Izvirni znanstveni članek
Oznake: glioblastoma;stem cells;nanobodies;cell migration;citotoxicity;vimentin;DPYSL2;NAP1L1;TUFM;
Background: Glioblastoma is a particularly common and very aggressive primary brain tumour. One of the main causes of therapy failure is the presence of glioblastoma stem cells that are resistant to chemotherapy and radiotherapy, and that have the potential to form new tumours. This study focuses on ...
Leto: 2020 Vir: Medicinska fakulteta (UL MF)
Meta-analysis and experimental validation identified FREM2 and SPRY1 as new glioblastoma marker candidates
Marko Vidak, Ivana Jovchevska, Neja Zupanec, Alja Zottel, Mirjana Liović, Damjana Rozman, Sašo Džeroski, Peter Juvan, Radovan Komel
Izvirni znanstveni članek
Oznake: glioblastom;23/5000 matične celice glioblastoma;biomarkerji;glioblastoma;glioblastoma stem cells;biomarkers;
Glioblastoma (GB) is the most aggressive brain malignancy. Although some potential glioblastoma biomarkers have already been identified, there is a lack of cell membrane-bound biomarkers capable of distinguishing brain tissue from glioblastoma and/or glioblastoma stem cells (GSC), which are responsi ...
Leto: 2018 Vir: Medicinska fakulteta (UL MF)
Anti-vimentin nanobody decreases glioblastoma cell invasion in vitro and in vivo
Alja Zottel, Alja Zottel, Metka Novak, Neja Zupanec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik, Ivana Jovchevska, Ivana Jovchevska
Izvirni znanstveni članek
Oznake: glioblastom;vimentin;nanotelo;glioblastoma;nanobody;
Purpose: Glioblastoma (GBM) is the most common primary brain tumour and one of the deadliest cancers. In addition to late diagnosis and inadequate treatment, the extremely low survival rate is also due to the lack of appropriate therapeutic biomarkers and corresponding therapeutic agents. One of the ...
Leto: 2023 Vir: Medicinska fakulteta (UL MF)
TRIM28 selective nanobody reduces glioblastoma stem cell invasion
Andrej Porčnik, Metka Novak, Barbara Breznik, Bernarda Majc, Barbara Hrastar, Neja Zupanec, Alja Zottel, Ivana Jovchevska, Miloš Vittori, Ana Rotter, Radovan Komel, Tamara Lah Turnšek
Izvirni znanstveni članek
Oznake: glioblastom;TRIM28;nanoprotitelesa;
Glioblastoma (GB), is the most common and aggressive malignant primary brain tumour in adults. Intra- and inter-tumour heterogeneity, infiltrative GB cell invasion and presence of therapy-resistant GB stem cells (GSCs) represent major obstacles to favourable prognosis and poor therapy response. Iden ...
Leto: 2021 Vir: Medicinska fakulteta (UL MF)
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in glioblastoma cell lines and extracellular vesicles
Alja Zottel, Neja Zupanec, Ana Kump, Lucija Raspor Dall'Olio, Pia Pužar Dominkuš, Rok Romih, Samo Hudoklin, Jernej Mlakar, Daniil Nikitin, Maxim Sorokin, Anton A. Buzdin, Ivana Jovchevska, Radovan Komel
Izvirni znanstveni članek
Oznake: glioblastom;biomarkerji;eksosomi;glioblastoma;biomarkers;exosomes;
Glioblastoma (GBM), the most common primary brain tumor, is a complex and extremely aggressive disease. Despite recent advances in molecular biology, there is a lack of biomarkers, which would improve GBM's diagnosis, prognosis, and therapy. Here, we analyzed by qPCR the expression levels of a set o ...
Leto: 2020 Vir: Medicinska fakulteta (UL MF)
Št. zadetkov: 9
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: